Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Breakthrough in tracking the spread of esophageal cancer cells

Scientists funded by the Cancer Research Campaign at the University of Newcastle upon Tyne have developed a way of accurately predicting the spread of esophageal cancer - leading to hopes of life-saving improvements in surgery.

News image

fiogf49gjkf04

Using colored dye and a radioactive tracking device, the researchers can track the routes of renegade cancer cells as they break away from the main tumor and start to spread around the body.

The technique predicts with 95% accuracy the tissues which should be removed by surgery and which can be left alone.

This could allow doctors to individually tailor each patient's surgery to provide the best chance of cure.

By identifying the favored escape routes, the researchers hope to predict which lymph glands needed to be surgically removed to stop the cancer from spreading.

The researchers have already studied the lymph nodes of 40 people with esophageal cancer, and plan to examine 30 more.

Before having an operation to remove their tumor, each patient has blue dye and a harmless radioactive molecule called "Technetium99-labelled colloid" injected into the edges of the tumor, via a camera placed in the esophagus.

During surgery, a medical physicist monitors the flow of radioactivity through the lymphatic system using a hand-held probe.

Then, at the end of the operation, researchers measure the amounts of radiation and of blue dye within each lymph node. This tells them the precise lymphatic pathways that are draining the tumor.

The pathology research team then cuts open and examines the lymph nodes.

The technique predicts cancerous tissues to be removed with 95% accuracy.
The University of Newcastle upon Tyne
Both conventional techniques and immunohistochemistry are used to verify the presence of even single cancer cells. This process is very accurate, but time-consuming and laborious.

At the moment there are far too many lymph nodes (40 per patient) to test them all with immunohistochemistry. However, the new technique could allow doctors to narrow down the search for escaping cancer cells to less than 3 lymph nodes, which could then be examined in greater detail.

Team leader, Professor Michael Griffin says, "The type of esophageal cancer we're looking at is among the fastest increasing cancers in the UK. Unfortunately, at the time of diagnosis, most have already started to spread to the surrounding lymph glands.

"Our main hope of slowing the cancer's progress is to remove the affected lymph glands, but at present it is difficult to identify the glands that need to be removed for each patient.

"Hopefully, our research will predict the spread of cancer much more accurately, allowing us to remove the affected lymph glands while leaving those that are free of cancer alone."

Professor Gordon McVie, Director General of the Cancer Research Campaign, says, "Professor Griffin's work should provide valuable information about which lymph glands the esophageal cancer is likely to have reached. Hopefully, doctors will be able to design surgery for the individual patient, maximizing the chance of cure, while minimizing the severity of the operation."

The University of Newcastle upon Tyne
13 September 2001

Go to top of page Email this page Email this page to a colleague

 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Socioeconomic characteristics in diverticular disease
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Barriers to hepatitis C treatment
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 31 October 2017 
Endoscopic indices of disease activity for Crohn’s
 31 October 2017 
Follow-up of positive results on fecal blood tests
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Hospital readmissions reduction program
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening
 19 October 2017 
Current management of chylous ascites

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us